Descargar PDF
1 / Páginas

Otros usuarios también vieron estos artículos

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH¿AEG¿SEPD¿SEOM¿GETECCU Mar Riveiro-Barciela; Sabela Carballal; Álvaro Díaz-González; Míriam Mañosa; Javier Gallego-Plazas; Joaquín Cubiella; Paula Jiménez-Fonseca; María Varela; Luis Menchén; Bruno Sangro; Ana Fernández-Montes; Francisco Mesonero; Miguel Ángel Rodríguez-Gandía; Fernando Rivera; María-Carlota Londoño;
Gastroenterol Hepatol. 2024;47:401-32
High incidence of surgery and initiation of medical therapies after colectomy for ulcerative colitis or inflammatory bowel disease unclassified Laura Núñez; Francisco Mesonero; Enrique Rodríguez de Santiago; Javier Die; Agustín Albillos; Antonio López-Sanromán;
Gastroenterol Hepatol. 2023;46:369-75
Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapy Edgar Castillo-Regalado; Raquel Ríos; Clàudia Aràjol; Cristina Gely; Lucía Márquez; Margalida Calafat; Carlos González-Muñoza; Fiorella Cañete; Francisco Mesonero; Jordi Guardiola; Esther Garcia-Planella; Míriam Mañosa; Eugeni Domènech;
Gastroenterol Hepatol. 2023;46:164-70